SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-041871
Filing Date
2014-02-10
Accepted
2014-02-10 08:02:47
Documents
15
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d649790d20f.htm 20-F 2754898
2 EX-2.30 d649790dex230.htm EX-2.30 565284
3 EX-2.31 d649790dex231.htm EX-2.31 81406
4 EX-8 d649790dex8.htm EX-8 5631
5 EX-10 d649790dex10.htm EX-10 2560
6 EX-12.(I) d649790dex12i.htm EX-12.(I) 6231
7 EX-12.(II) d649790dex12ii.htm EX-12.(II) 9486
8 EX-13 d649790dex13.htm EX-13 4736
15 GRAPHIC g649790g99y37.jpg GRAPHIC 1914
  Complete submission text file 0001193125-14-041871.txt   18715474

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT teva-20131231.xml EX-101.INS 2910768
10 XBRL TAXONOMY EXTENSION SCHEMA teva-20131231.xsd EX-101.SCH 198392
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20131231_cal.xml EX-101.CAL 165014
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20131231_def.xml EX-101.DEF 561029
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20131231_lab.xml EX-101.LAB 1179851
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20131231_pre.xml EX-101.PRE 1067083
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-16174 | Film No.: 14586223
SIC: 2834 Pharmaceutical Preparations